{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:53:56Z","timestamp":1781909636779,"version":"3.54.5"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T00:00:00Z","timestamp":1196985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p><jats:bold>Objectives:\u2002<\/jats:bold> Recently, an allelic loss of phosphatase and tensin homologue (PTEN) was shown to occur in ameloblastomas. In carcinogenesis, loss of PTEN allows for overactivity of the phosphatidylinositol\u20103\u2010kinase\/protein kinase B (PI3K\u200a\/\u200aAKT) pathway inducing an upregulation of mammalian\u2010target of rapamycin (mTOR) and its downstream effector ribosomal\u2010subunit\u20106 kinase (S6K); allowing for uncontrolled cell proliferation, apoptosis inhibition and cell cycle deregulation.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Thirty ameloblastomas and five dental follicles were studied, looking at the immunohistochemical expression of total PTEN and AKT, as well as their phosphorylated (p) active forms, and the downstream effector and indicator of mTOR activity p70 ribosomal\u2010subunit\u20106 kinase (pS6K). Also assessed was the expression of extracellular\u2010signal\u2010regulated kinase (ERK), which cross talks with AKT.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Total PTEN was absent in 33.3% of ameloblastomas, while its stabilized, phosphorylated<jats:sup>ser380\u200a\/\u200athr382\u200a\/\u200athr383<\/jats:sup> form was absent in 83.3% of tumors. In contrast, AKT was expressed in 83.3% of ameloblastomas, showing high expression of the p\u2010thr<jats:sup>308<\/jats:sup>AKT and p\u2010ser<jats:sup>473<\/jats:sup> AKT forms in 93.3% and 56.6% of cases, respectively. Further, the mTOR activated pS6K<jats:sup>ser240\u200a\/\u200a244<\/jats:sup> was detected in 86.7% of ameloblastomas, while ERK was overexpressed in 70.0% of the cases.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Immunohistochemical analysis of aberrant signaling in the PI3K\/AKT\/mTOR pathway in ameloblastomas may represent a valuable tool for elucidating pathogenesis, aggressiveness and selecting optimal therapeutics.<\/jats:p>","DOI":"10.1111\/j.1601-0825.2007.01421.x","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T06:07:20Z","timestamp":1218607640000},"page":"561-568","source":"Crossref","is-referenced-by-count":28,"title":["Expression and alterations of the PTEN\u200a\/\u200aAKT\u200a\/\u200amTOR pathway in ameloblastomas"],"prefix":"10.1111","volume":"14","author":[{"given":"MA","family":"Scheper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Chaisuparat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NG","family":"Nikitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JJ","family":"Sauk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,8,13]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00497.x"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1362"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2006.05.019"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.8.4240"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.11.032"},{"key":"e_1_2_5_7_1","first-page":"1299","article-title":"ERK implication in cell cycle regulation","volume":"17","author":"Chambard JC","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210202"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2006.03.022"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.08.008"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2004.09.014"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1494"},{"key":"e_1_2_5_13_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj3510289","article-title":"Meaningful relationships: the regulation of the Ras\u200a\/\u200aRaf\u200a\/\u200aMEK\u200a\/\u200aERK pathway by protein interactions","volume":"351","author":"Kolch W","year":"2000","journal-title":"Biochem J"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2005.00354.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00432.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00458.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00381.x"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2007.00516.x"},{"key":"e_1_2_5_19_1","first-page":"69","article-title":"Ameloblastoma: analysis of 207 cases in a Nigerian teaching hospital","volume":"37","author":"Ladeinde AL","year":"2006","journal-title":"Quintessence Int"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2006.03.012"},{"key":"e_1_2_5_21_1","first-page":"611","volume-title":"Oral and maxillofacial pathology","author":"Neville BW","year":"2002"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800147"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0964-1955(94)00037-5"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2003.08.011"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000087564"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.09.009"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.04.011"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2005.06.026"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2004.08.026"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04869"},{"key":"e_1_2_5_31_1","first-page":"997","article-title":"Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas","volume":"21","author":"Shin KH","year":"2002","journal-title":"Int J Oncol"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2005.tb00337.x"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2006.04.005"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2002.00142.x"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2006.02064.x"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc839"},{"key":"e_1_2_5_37_1","first-page":"7","article-title":"Association of matrix metalloproteinase\u20102 activity with cell proliferation and growth in ameloblastoma","volume":"24","author":"Zhang B","year":"2006","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"key":"e_1_2_5_38_1","first-page":"461","article-title":"Expression and significance of hTERT, c\u2010fos and c\u2010jun in ameloblastoma","volume":"15","author":"Zhong M","year":"2006","journal-title":"Shanghai Kou Qiang Yi Xue"},{"key":"e_1_2_5_39_1","first-page":"495","article-title":"Expression of cyclin D1 and its inhibitors and hTERT in ameloblastoma","volume":"24","author":"Zhong M","year":"2006","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.2007.01421.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.2007.01421.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:48:27Z","timestamp":1696985307000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.2007.01421.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,13]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1601-0825.2007.01421.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.2007.01421.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,13]]}}}